Direct costs associated with adverse events of systemic therapies for advanced melanoma: Systematic literature review.

ABSTRACT:

Background

Treatments for advanced melanoma are associated with different adverse events (AEs), which may be costly to manage. This study aimed to evaluate direct costs associated with managing treatment-related AEs for advanced melanoma through a systematic literature review.

Methods

Systematic searches were conducted of the PubMed, Embase, Cochrane, BIOSIS, and EconLit medical literature databases to identify studies providing estimates of direct costs and health care resource utilization for the management of AEs of melanoma treatments, published between January 1, 2007, and February 23, 2017. Gray literature searches also were conducted. Studies reporting direct costs for patients with advanced melanoma that were published in English between 2007 and 2017 were eligible.

SUBMITTER: Copley-Merriman C 

PROVIDER: S-EPMC6081130 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature